scholarly journals ErbB-2 Blockade and Prenyltransferase Inhibition Alter Epidermal Growth Factor and Epidermal Growth Factor Receptor Trafficking and Enhance 111In-DTPA-hEGF Auger Electron Radiation Therapy

2011 ◽  
Vol 52 (5) ◽  
pp. 776-783 ◽  
Author(s):  
B. Cornelissen ◽  
S. Darbar ◽  
R. Hernandez ◽  
V. Kersemans ◽  
I. Tullis ◽  
...  
Oncotarget ◽  
2017 ◽  
Vol 8 (20) ◽  
pp. 33316-33328 ◽  
Author(s):  
Akio Soeda ◽  
Justin Lathia ◽  
Brian J. Williams ◽  
Qiulian Wu ◽  
Joseph Gallagher ◽  
...  

2019 ◽  
Vol 12 (8) ◽  
pp. e228882 ◽  
Author(s):  
Shivanshan Pathmanathan ◽  
Marcin Dzienis

A 52-year-old male patient with hyaluronic acid-based dermal fillers injected in his cheeks was diagnosed with glossotonsillary malignancy, and managed with concurrent cetuximab (epidermal growth factor receptor inhibitor) and radiation therapy. He developed significant inflammation around the dermal filler sites after first cycle of cetuximab which improved with dissolution of the dermal fillers with hyaluronidase. This suggests that cetuximab can lead to inflammation around the dermal filler sites, which can be treated with dissolution of the filler.


2014 ◽  
Vol 13 (11) ◽  
pp. 2559-2571 ◽  
Author(s):  
Khalil Dayekh ◽  
Stephanie Johnson-Obaseki ◽  
Martin Corsten ◽  
Patrick J. Villeneuve ◽  
Harmanjatinder S. Sekhon ◽  
...  

2007 ◽  
Vol 67 (19) ◽  
pp. 9229-9237 ◽  
Author(s):  
Jayoung Kim ◽  
Wan Jin Jahng ◽  
Dolores Di Vizio ◽  
Julie S. Lee ◽  
Raj Jhaveri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document